231 related articles for article (PubMed ID: 38270933)
1. Health-related quality of life with standard and curative therapies in thalassemia: A narrative literature review.
Shah R; Badawy SM
Ann N Y Acad Sci; 2024 Feb; 1532(1):50-62. PubMed ID: 38270933
[TBL] [Abstract][Full Text] [Related]
2. Deferasirox for the treatment of iron overload in non-transfusion-dependent thalassemia.
Taher AT; Temraz S; Cappellini MD
Expert Rev Hematol; 2013 Oct; 6(5):495-509. PubMed ID: 24083402
[TBL] [Abstract][Full Text] [Related]
3. Deferasirox: a review of its use for chronic iron overload in patients with non-transfusion-dependent thalassaemia.
Shirley M; Plosker GL
Drugs; 2014 Jun; 74(9):1017-27. PubMed ID: 24919862
[TBL] [Abstract][Full Text] [Related]
4. Iron overload in thalassemia: different organs at different rates.
Taher AT; Saliba AN
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):265-271. PubMed ID: 29222265
[TBL] [Abstract][Full Text] [Related]
5. Marital status and paternity in patients with Transfusion- Dependent Thalassemia (TDT) and Non Transfusion-Dependent Thalassemia (NTDT): an ICET - A survey in different countries.
De Sanctis V; Soliman AT; El-Hakim I; Christou S; Mariannis D; Karimi M; Ladis V; Kattamis A; Daar S; Yassin M; Canatan D; Galati MC; Raiola G; Campisi S; Kakkar S; Kaleva V; Saki F; Ellinides A; Pikis G; Christodoulides C; Abdulla M; Di Maio S; Theodoridis C; Elsedfy H; Kattamis C
Acta Biomed; 2019 Sep; 90(3):225-237. PubMed ID: 31580308
[TBL] [Abstract][Full Text] [Related]
6. A pharmaco-economic evaluation of deferasirox for treating patients with iron overload caused by transfusion-dependent thalassemia in Taiwan.
Ho WL; Chung KP; Yang SS; Lu MY; Jou ST; Chang HH; Yang YL; Lin DT; Lin KH
J Formos Med Assoc; 2013 Apr; 112(4):221-9. PubMed ID: 23537869
[TBL] [Abstract][Full Text] [Related]
7. Non-Transfusion-Dependent Thalassemia: A Panoramic Review.
Shash H
Medicina (Kaunas); 2022 Oct; 58(10):. PubMed ID: 36295656
[TBL] [Abstract][Full Text] [Related]
8. Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management.
Vichinsky E
Curr Med Res Opin; 2016; 32(1):191-204. PubMed ID: 26479125
[TBL] [Abstract][Full Text] [Related]
9. New therapeutic targets in transfusion-dependent and -independent thalassemia.
Cappellini MD; Motta I
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
[TBL] [Abstract][Full Text] [Related]
10. Iron Chelation Therapy as a Modality of Management.
Aydinok Y
Hematol Oncol Clin North Am; 2018 Apr; 32(2):261-275. PubMed ID: 29458731
[TBL] [Abstract][Full Text] [Related]
11. Deferasirox for managing iron overload in people with thalassaemia.
Bollig C; Schell LK; Rücker G; Allert R; Motschall E; Niemeyer CM; Bassler D; Meerpohl JJ
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD007476. PubMed ID: 28809446
[TBL] [Abstract][Full Text] [Related]
12. Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes.
Ricchi P; Marsella M
Drug Des Devel Ther; 2015; 9():6475-82. PubMed ID: 26719673
[TBL] [Abstract][Full Text] [Related]
13. Combined chelation with high-dose deferiprone and deferoxamine to improve survival and restore cardiac function effectively in patients with transfusion-dependent thalassemia presenting severe cardiac complications.
Chuang TY; Li JP; Weng TF; Wu KH; Chao YH
Ann Hematol; 2020 Oct; 99(10):2289-2294. PubMed ID: 32737633
[TBL] [Abstract][Full Text] [Related]
14. Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.
Fisher SA; Brunskill SJ; Doree C; Gooding S; Chowdhury O; Roberts DJ
Cochrane Database Syst Rev; 2013 Aug; (8):CD004450. PubMed ID: 23963793
[TBL] [Abstract][Full Text] [Related]
15. Deferasirox in children with transfusion-dependent thalassemia or sickle cell anemia: A large cohort real-life experience from Turkey (REACH-THEM).
Antmen B; Karakaş Z; Yeşilipek MA; Küpesiz OA; Şaşmaz İ; Uygun V; Kurtoğlu E; Oktay G; Aydogan G; Akın M; Salcioglu Z; Vergin C; Kazancı EG; Ünal S; Çalışkan Ü; Aral YZ; Türkkan E; Meral Güneş A; Tunç B; Gümrük F; Ayhan AC; Söker M; Koç A; Oymak Y; Ertem M; Timur Ç; Yıldırmak Y; İrken G; Apak H; Biner B; Eren TG; Işık Balcı Y; Koçak Ü; Karasu G; Akkaynak D; Patıroğlu T
Eur J Haematol; 2019 Feb; 102(2):123-130. PubMed ID: 30300449
[TBL] [Abstract][Full Text] [Related]
16. Morbidities in non-transfusion-dependent thalassemia.
Saliba AN; Taher AT
Ann N Y Acad Sci; 2016 Mar; 1368(1):82-94. PubMed ID: 27186941
[TBL] [Abstract][Full Text] [Related]
17. Relationship among chelator adherence, change in chelators, and quality of life in thalassemia.
Trachtenberg FL; Gerstenberger E; Xu Y; Mednick L; Sobota A; Ware H; Thompson AA; Neufeld EJ; Yamashita R;
Qual Life Res; 2014 Oct; 23(8):2277-88. PubMed ID: 24682717
[TBL] [Abstract][Full Text] [Related]
18. Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia.
Viprakasit V; Hamdy MM; Hassab HMA; Sherief LM; Al-Bagshi M; Khattab M; Chuncharunee S; Dung PC; Küpesiz A; Shekhawat A; Sonawane Y; Perez LT; Slader C; Taher AT
Ann Hematol; 2023 Aug; 102(8):2039-2049. PubMed ID: 37227493
[TBL] [Abstract][Full Text] [Related]
19. Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.
Sleiman J; Tarhini A; Bou-Fakhredin R; Saliba AN; Cappellini MD; Taher AT
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29316681
[TBL] [Abstract][Full Text] [Related]
20. Spanish registry of hemoglobinopathies and rare anemias (REHem-AR): demographics, complications, and management of patients with β-thalassemia.
Bardón-Cancho EJ; Marco-Sánchez JM; Benéitez-Pastor D; Payán-Pernía S; Llobet AR; Berrueco R; García-Morin M; Beléndez C; Senent L; Acosta MJO; Pleguezuelos IP; Velasco P; Collado A; Moreno-Carbonell M; Argilés B; de Soto IP; Del Mar Bermúdez M; Salido Fiérrez EJ; Blanco-Álvarez A; Navarro PG; Cela E
Ann Hematol; 2024 May; 103(5):1525-1539. PubMed ID: 38519604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
